199 related articles for article (PubMed ID: 35773398)
1. Neutralization mechanism of a human antibody with pan-coronavirus reactivity including SARS-CoV-2.
Sun X; Yi C; Zhu Y; Ding L; Xia S; Chen X; Liu M; Gu C; Lu X; Fu Y; Chen S; Zhang T; Zhang Y; Yang Z; Ma L; Gu W; Hu G; Du S; Yan R; Fu W; Yuan S; Qiu C; Zhao C; Zhang X; He Y; Qu A; Zhou X; Li X; Wong G; Deng Q; Zhou Q; Lu H; Ling Z; Ding J; Lu L; Xu J; Xie Y; Sun B
Nat Microbiol; 2022 Jul; 7(7):1063-1074. PubMed ID: 35773398
[TBL] [Abstract][Full Text] [Related]
2. Neutralizing Monoclonal Antibodies Inhibit SARS-CoV-2 Infection through Blocking Membrane Fusion.
Li CJ; Chao TL; Chang TY; Hsiao CC; Lu DC; Chiang YW; Lai GC; Tsai YM; Fang JT; Ieong S; Wang JT; Chang SY; Chang SC
Microbiol Spectr; 2022 Apr; 10(2):e0181421. PubMed ID: 35293796
[TBL] [Abstract][Full Text] [Related]
3. Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray.
Camerini D; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Shandling A; Huynh V; Teng AA; Hermanson G; Pablo JV; Stumpf MM; Lester SN; Harcourt J; Tamin A; Rasheed M; Thornburg NJ; Satheshkumar PS; Liang X; Kennedy RB; Yee A; Townsend M; Campo JJ
Microbiol Spectr; 2021 Oct; 9(2):e0141621. PubMed ID: 34704808
[TBL] [Abstract][Full Text] [Related]
4. Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit.
Hurlburt NK; Homad LJ; Sinha I; Jennewein MF; MacCamy AJ; Wan YH; Boonyaratanakornkit J; Sholukh AM; Jackson AM; Zhou P; Burton DR; Andrabi R; Ozorowski G; Ward AB; Stamatatos L; Pancera M; McGuire AT
Commun Biol; 2022 Apr; 5(1):342. PubMed ID: 35411021
[TBL] [Abstract][Full Text] [Related]
5. Identification of a conserved S2 epitope present on spike proteins from all highly pathogenic coronaviruses.
Silva RP; Huang Y; Nguyen AW; Hsieh CL; Olaluwoye OS; Kaoud TS; Wilen RE; Qerqez AN; Park JG; Khalil AM; Azouz LR; Le KC; Bohanon AL; DiVenere AM; Liu Y; Lee AG; Amengor DA; Shoemaker SR; Costello SM; Padlan EA; Marqusee S; Martinez-Sobrido L; Dalby KN; D'Arcy S; McLellan JS; Maynard JA
Elife; 2023 Mar; 12():. PubMed ID: 36942851
[TBL] [Abstract][Full Text] [Related]
6. Epitope-directed anti-SARS-CoV-2 scFv engineered against the key spike protein region could block membrane fusion.
Jaiswal D; Kumar U; Gaur V; Salunke DM
Protein Sci; 2023 Mar; 32(3):e4575. PubMed ID: 36691733
[TBL] [Abstract][Full Text] [Related]
7. Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer.
Zhan W; Tian X; Zhang X; Xing S; Song W; Liu Q; Hao A; Hu Y; Zhang M; Ying T; Chen Z; Lan F; Sun L
J Virol; 2022 Aug; 96(16):e0048022. PubMed ID: 35924918
[TBL] [Abstract][Full Text] [Related]
8. Human neutralizing antibodies to cold linear epitopes and subdomain 1 of the SARS-CoV-2 spike glycoprotein.
Bianchini F; Crivelli V; Abernathy ME; Guerra C; Palus M; Muri J; Marcotte H; Piralla A; Pedotti M; De Gasparo R; Simonelli L; Matkovic M; Toscano C; Biggiogero M; Calvaruso V; Svoboda P; Cervantes Rincón T; Fava T; Podešvová L; Shanbhag AA; Celoria A; Sgrignani J; Stefanik M; Hönig V; Pranclova V; Michalcikova T; Prochazka J; Guerrini G; Mehn D; Ciabattini A; Abolhassani H; Jarrossay D; Uguccioni M; Medaglini D; Pan-Hammarström Q; Calzolai L; Fernandez D; Baldanti F; Franzetti-Pellanda A; Garzoni C; Sedlacek R; Ruzek D; Varani L; Cavalli A; Barnes CO; Robbiani DF
Sci Immunol; 2023 Mar; 8(81):eade0958. PubMed ID: 36701425
[TBL] [Abstract][Full Text] [Related]
9. Insight into vaccine development for Alpha-coronaviruses based on structural and immunological analyses of spike proteins.
Shi Y; Shi J; Sun L; Tan Y; Wang G; Guo F; Hu G; Fu Y; Fu ZF; Xiao S; Peng G
J Virol; 2021 Mar; 95(7):. PubMed ID: 33414160
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 spike engagement of ACE2 primes S2' site cleavage and fusion initiation.
Yu S; Zheng X; Zhou B; Li J; Chen M; Deng R; Wong G; Lavillette D; Meng G
Proc Natl Acad Sci U S A; 2022 Jan; 119(1):. PubMed ID: 34930824
[TBL] [Abstract][Full Text] [Related]
11. Cross-Neutralization of Emerging SARS-CoV-2 Variants of Concern by Antibodies Targeting Distinct Epitopes on Spike.
Changrob S; Fu Y; Guthmiller JJ; Halfmann PJ; Li L; Stamper CT; Dugan HL; Accola M; Rehrauer W; Zheng NY; Huang M; Wang J; Erickson SA; Utset HA; Graves HM; Amanat F; Sather DN; Krammer F; Kawaoka Y; Wilson PC
mBio; 2021 Dec; 12(6):e0297521. PubMed ID: 34781736
[TBL] [Abstract][Full Text] [Related]
12. Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.
Essalmani R; Jain J; Susan-Resiga D; Andréo U; Evagelidis A; Derbali RM; Huynh DN; Dallaire F; Laporte M; Delpal A; Sutto-Ortiz P; Coutard B; Mapa C; Wilcoxen K; Decroly E; Nq Pham T; Cohen ÉA; Seidah NG
J Virol; 2022 Apr; 96(8):e0012822. PubMed ID: 35343766
[TBL] [Abstract][Full Text] [Related]
13. An ultrapotent pan-β-coronavirus lineage B (β-CoV-B) neutralizing antibody locks the receptor-binding domain in closed conformation by targeting its conserved epitope.
Liu Z; Xu W; Chen Z; Fu W; Zhan W; Gao Y; Zhou J; Zhou Y; Wu J; Wang Q; Zhang X; Hao A; Wu W; Zhang Q; Li Y; Fan K; Chen R; Jiang Q; Mayer CT; Schoofs T; Xie Y; Jiang S; Wen Y; Yuan Z; Wang K; Lu L; Sun L; Wang Q
Protein Cell; 2022 Sep; 13(9):655-675. PubMed ID: 34554412
[TBL] [Abstract][Full Text] [Related]
14. Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability.
Shi W; Wang L; Zhou T; Sastry M; Yang ES; Zhang Y; Chen M; Chen X; Choe M; Creanga A; Leung K; Olia AS; Pegu A; Rawi R; Schön A; Shen CH; Stancofski ED; Talana CA; Teng IT; Wang S; Corbett KS; Tsybovsky Y; Mascola JR; Kwong PD
Structure; 2022 Sep; 30(9):1233-1244.e7. PubMed ID: 35841885
[TBL] [Abstract][Full Text] [Related]
15. Immunity against seasonal human coronavirus OC43 mitigates fatal deterioration of COVID-19.
Yamaguchi T; Shinagawa T; Kobata H; Nakagawa H
Int J Infect Dis; 2021 Aug; 109():261-268. PubMed ID: 34273512
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
Elife; 2022 Jan; 11():. PubMed ID: 35072628
[TBL] [Abstract][Full Text] [Related]
17. Impact of SARS-CoV-2 Spike Mutations on Its Activation by TMPRSS2 and the Alternative TMPRSS13 Protease.
Stevaert A; Van Berwaer R; Mestdagh C; Vandeput J; Vanstreels E; Raeymaekers V; Laporte M; Naesens L
mBio; 2022 Aug; 13(4):e0137622. PubMed ID: 35913162
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner.
Lavie M; Dubuisson J; Belouzard S
J Virol; 2022 Jul; 96(13):e0047422. PubMed ID: 35678602
[TBL] [Abstract][Full Text] [Related]
19. Cross-reactive antibodies elicited to conserved epitopes on SARS-CoV-2 spike protein after infection and vaccination.
Geanes ES; LeMaster C; Fraley ER; Khanal S; McLennan R; Grundberg E; Selvarangan R; Bradley T
Sci Rep; 2022 Apr; 12(1):6496. PubMed ID: 35444221
[TBL] [Abstract][Full Text] [Related]
20. A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
Shi J; Zheng J; Tai W; Verma AK; Zhang X; Geng Q; Wang G; Guan X; Malisheni MM; Odle AE; Zhang W; Li F; Perlman S; Du L
J Virol; 2022 Sep; 96(17):e0011822. PubMed ID: 35972290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
